Serotonin-norepinephrine reuptake inhibitors

Results: 200



#Item
51N21-427S043 Duloxetine Clinical BPCA

N21-427S043 Duloxetine Clinical BPCA

Add to Reading List

Source URL: www.fda.gov

Language: English
52MERIDIA® (sibutramine hydrochloride monohydrate) Capsules CS-IV DESCRIPTION MERIDIA® (sibutramine hydrochloride monohydrate) is an orally administered agent for the treatment of obesity. Chemically, the active ingredie

MERIDIA® (sibutramine hydrochloride monohydrate) Capsules CS-IV DESCRIPTION MERIDIA® (sibutramine hydrochloride monohydrate) is an orally administered agent for the treatment of obesity. Chemically, the active ingredie

Add to Reading List

Source URL: www.fda.gov

Language: English
53Lexapro (escitalopram oxalate) Tablets/Oral Solution NDA[removed]NDA[removed]Proposed Labeling Text Lexapro®

Lexapro (escitalopram oxalate) Tablets/Oral Solution NDA[removed]NDA[removed]Proposed Labeling Text Lexapro®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:03
54Effexorâ XR (venlafaxine hydrochloride) Extended-Release Capsules ] only This product’s label may have been revised after this insert was used

Effexorâ XR (venlafaxine hydrochloride) Extended-Release Capsules ] only This product’s label may have been revised after this insert was used

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-06-08 09:31:21
55U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

Add to Reading List

Source URL: www.fda.gov

Language: English
56Highlights Of Prescribing Information These highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets

Highlights Of Prescribing Information These highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:08
571  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cymbalta safely and effectively. See full prescribing information for Cymbalta.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cymbalta safely and effectively. See full prescribing information for Cymbalta.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:51:06
58FIBROMYALGIA (FM) FM-CFS Canada FIBROMYALGIA FOR PHARMACISTS Janice Sumpton, RPh, BSc.Phm

FIBROMYALGIA (FM) FM-CFS Canada FIBROMYALGIA FOR PHARMACISTS Janice Sumpton, RPh, BSc.Phm

Add to Reading List

Source URL: fm-cfs.ca

Language: English - Date: 2013-12-09 15:09:41
59New Drugs DULOXETINE (Cymbalta®) Submitted by Dan Anderson, Los Angeles County Dept. of Coroner [removed]

New Drugs DULOXETINE (Cymbalta®) Submitted by Dan Anderson, Los Angeles County Dept. of Coroner [removed]

Add to Reading List

Source URL: www.cal-tox.org

Language: English - Date: 2010-09-16 16:37:19
60Effexor®  (venlafaxine hydrochloride) Tablets

Effexor® (venlafaxine hydrochloride) Tablets

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:50:52